Inventor · disambiguated record
Hua-Xin Liao
Also filed as: LIAO HUA-XIN
40 granted patents·35 pending applications·210 citations·filing 1993–2025
97Inventor score
Files withUNIV DUKE46HAYNES BARTON F16BETH ISRAEL HOSPITAL3KORBER BETTE T2LOS ALAMOS NAT SECURITY LLC2
Top patents by PatentIndex Score
75 records- 0196US7951377B2Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogensLOS ALAMOS NAT SECURITY LLC·Filed 2008·Granted May 31, 2011·37 cites·6 claims
- 0291US11136380B2Anti-complement factor H antibodiesUNIV DUKE·Filed 2018·Granted Oct 5, 2021·6 cites·14 claims
- 0389US8071107B2Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteinsHAYNES BARTON F·Filed 2004·Granted Dec 6, 2011·26 cites·8 claims
- 0488US10865238B1Complement factor H antibodiesUNIV DUKE·Filed 2018·Granted Dec 15, 2020·5 cites·12 claims
- 0587US10183988B2Anti-Complement factor H antibodiesUNIV DUKE·Filed 2014·Granted Jan 22, 2019·7 cites·15 claims
- 0687US9011873B2Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogensKORBER BETTE T·Filed 2011·Granted Apr 21, 2015·4 cites·18 claims
- 0787US7172761B2Polyvalent immunogenUNIV CALIFORNIA·Filed 2003·Granted Feb 6, 2007·18 cites·9 claims
- 0886US12286471B2Inhibitors of complement factor HUNIV DUKE·Filed 2024·Granted Apr 29, 2025·0 cites·6 claims
- 0986US9044445B2Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogensKORBER BETTE T·Filed 2009·Granted Jun 2, 2015·4 cites·18 claims
- 1085US7070787B2Method of inducing the production of antibodies to HIVUNIV DUKE·Filed 2003·Granted Jul 4, 2006·10 cites·18 claims
- 1185US7033593B2Immunogen comprising an HIV envelope protein, a ligand and H2 peptideUNIV DUKE·Filed 2003·Granted Apr 25, 2006·11 cites·28 claims
- 1284US10450368B2HIV-1 neutralizing antibodies and uses thereof (CD4bs antibodies)UNIV DUKE·Filed 2016·Granted Oct 22, 2019·5 cites·39 claims
- 1384US10004800B2Antibody evolution immunogensUNIV DUKE·Filed 2013·Granted Jun 26, 2018·6 cites·24 claims
- 1484US9402893B2Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodiesHAYNES BARTON F·Filed 2007·Granted Aug 2, 2016·5 cites·22 claims
- 1584US7101552B2Immunogen comprising an HIV envelope protein, a ligand and H2 peptideUNIV DUKE·Filed 2001·Granted Sep 5, 2006·9 cites·13 claims
- 1682US9844590B2Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogensLOS ALAMOS NAT SECURITY LLC·Filed 2015·Granted Dec 19, 2017·2 cites·9 claims
- 1782US9821053B2Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteinsUNIV DUKE·Filed 2015·Granted Nov 21, 2017·2 cites·18 claims
- 1882US9717789B2Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodiesUNIV DUKE·Filed 2016·Granted Aug 1, 2017·2 cites·18 claims
- 1981US10968255B2Compositions comprising HIV envelopes to induce CH235 lineage antibodiesUNIV DUKE·Filed 2017·Granted Apr 6, 2021·2 cites·16 claims
- 2081US7998471B2Mycobacteria expressing HIV-1 and malaria antigensEINSTEIN COLL MED·Filed 2006·Granted Aug 16, 2011·5 cites·14 claims
- 2180US2025282856A1Inhibitors of complement factor hUNIV DUKE·Filed 2025·Application pending·0 cites
- 2279US6544747B2Assay systemUNIV DUKE·Filed 2001·Granted Apr 8, 2003·7 cites·8 claims
- 2377US11071783B2HIV-1 neutralizing antibodies and uses thereofUNIV DUKE·Filed 2016·Granted Jul 27, 2021·2 cites·26 claims
- 2477US6982086B2Human immunodeficiency virus immunogenic compositionBETH ISRAEL HOSPITAL·Filed 2001·Granted Jan 3, 2006·7 cites·4 claims
- 2576US8956627B2Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugatesHAYNES BARTON F·Filed 2008·Granted Feb 17, 2015·2 cites·19 claims
- 2676US2025042980A1Complement factor h antibodiesUNIV DUKE·Filed 2023·Application pending·0 cites
- 2775US11897946B2Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFHUNIV DUKE·Filed 2021·Granted Feb 13, 2024·0 cites·17 claims
- 2874US9844589B2Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responsesHAYNES BARTON F·Filed 2011·Granted Dec 19, 2017·2 cites·11 claims
- 2967US11884704B2Compositions comprising HIV envelopes to induce CH235 lineage antibodiesUNIV DUKE·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 3067US10946090B2Consensus/ancestral immunogensUNIV DUKE·Filed 2017·Granted Mar 16, 2021·0 cites·18 claims
- 3166US10849970B2Antibody evolution immunogensUNIV DUKE·Filed 2018·Granted Dec 1, 2020·0 cites·30 claims
- 3265US7078039B2Immunogenic compositionBETH ISRAEL HOSPITAL·Filed 2004·Granted Jul 18, 2006·1 cites·5 claims
- 3364US10588960B2Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodiesUNIV DUKE·Filed 2017·Granted Mar 17, 2020·0 cites·16 claims
- 3463US10561725B2Method of inducing the production of protective anti-HIV-1 antibodiesUNIV DUKE·Filed 2013·Granted Feb 18, 2020·0 cites·20 claims
- 3563US5863540AAdhesion moleculeUNIV DUKE·Filed 1993·Granted Jan 26, 1999·23 cites·13 claims
- 3663US2021061891A1Complement factor h antibodiesUNIV DUKE·Filed 2020·Application pending·0 cites
- 3763US2018185471A1Polyvalent vaccineUNIV DUKE·Filed 2017·Application pending·0 cites
- 3860US2013323299A1Method of inducing neutralizing antibodies to human immunodeficiency virusHAYNES BARTON F·Filed 2013·Application pending·0 cites
- 3959US2010028415A1Method of Inducing Neutralizing Antibodies to Human Immunodeficiency VirusHAYNES BARTON F·Filed 2006·Application pending·0 cites
- 4058US7052699B2Immunogenic compositionBETH ISRAEL HOSPITAL·Filed 2004·Granted May 30, 2006·0 cites·5 claims
- 4158US2011159037A1Methods of treating and protecting against human immunodeficiency virusDUKE UNIVERISTY·Filed 2008·Application pending·0 cites
- 4257US2012183597A1Method of inducing neutralizing antibodies to human immunodeficiency virusHAYNES BARTON F·Filed 2011·Application pending·0 cites
- 4355US2007092936A1Severe acute respiratory syndromeHAYNES BARTON F·Filed 2004·Application pending·0 cites
- 4454US11944681B2HIV-1 neutralizing antibodies and uses thereofUNIV DUKE·Filed 2021·Granted Apr 2, 2024·0 cites·28 claims
- 4554US2008213296A1ImmunogenUNIV DUKE·Filed 2004·Application pending·0 cites
- 4652US2008038284A1Human Immunodeficiency Virus VaccineHAYNES BARTON F·Filed 2005·Application pending·0 cites
- 4751US2006204986A1ImmunogenUNIV DUKE·Filed 2006·Application pending·0 cites
- 4850US10286057B2Cyclic HIV-1 Env V3 glycopeptide immunogensUNIV DUKE·Filed 2014·Granted May 14, 2019·0 cites·17 claims
- 4950US2015147387A1Method of inducing antibodies to human immunodeficiency virus involving the administration of mper peptide-liposome conjugatesUNIV DUKE·Filed 2015·Application pending·0 cites
- 5049US2016039885A1Recombinant production of hiv-1 envelope glycoproteinsUNIV DUKE·Filed 2014·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hua-Xin Liao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →